We evaluated the utility of restriction spectrum imaging (RSI), a novel diffusion-based technique to detect and to characterize prostate cancer among men enrolled in a national cancer institute-funded prospective clinical trial of magnetic resonance ultrasound fusion biopsy. RSI was statistically significantly associated with clinically significant prostate cancer.
This abstract and the presentation materials are available to members only; a login is required.